Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Plano

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|January 30, 2014
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitorsDaniel Plano, Shantu Amin, Arun K Sharma
Mini Reviews in Medicinal Chemistry|September 11, 2008
Selenium compounds and apoptotic modulation: a new perspective in cancer therapyCarmen Sanmartín, Daniel Plano, Juan Antonio Palop
European Journal of Medicinal Chemistry|October 10, 2022
Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effectsSandra Ramos-Inza, Daniel Plano, Carmen Sanmartín
Molecules (Basel, Switzerland)|February 15, 2022
New Experimental Conditions for Diels-Alder and Friedel-Crafts Alquilation Reactions with Thiophene: A New Selenocyanate with Potent Activity against CancerGorka Calvo-Martín, Daniel Plano, Carmen Sanmartín
Current Cancer Drug Targets|March 15, 2011
Kinase regulation by sulfur and selenium containing compoundsCarmen Sanmartín, Daniel Plano, María Font, et al.
Expert Opinion on Therapeutic Patents|April 4, 2017
Methods of selecting combination therapy for colorectal cancer patients: a patent evaluation of US20160025730A1Daniel Plano, Verónica Alcolea, Carmen Sanmartín, et al.
Antioxidants (Basel, Switzerland)|June 2, 2021
Novel <i>N</i>,<i>N</i>'-Disubstituted Selenoureas as Potential Antioxidant and Cytotoxic AgentsGorka Calvo-Martín, Daniel Plano, Ignacio Encío, et al.
Journal of Molecular Graphics & Modelling|February 26, 2017
Topological and quantum molecular descriptors as effective tools for analyzing cytotoxic activity achieved by a series of (diselanediyldibenzene-4,1-diylnide)biscarbamate derivativesMaría Font, Daniel Plano, Carmen Sanmartín, et al.
Journal of the Science of Food and Agriculture|August 2, 2025
Selenium biofortification: integrating one health and sustainabilitySilvia Estarriaga-Navarro, Nieves Goicoechea, Daniel Plano, et al.
Molecules (Basel, Switzerland)|August 12, 2023
Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania TreatmentAndreina Henriquez-Figuereo, Esther Moreno, Carmen Sanmartin, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|January 30, 2014
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitorsDaniel Plano, Shantu Amin, Arun K Sharma
Mini Reviews in Medicinal Chemistry|September 11, 2008
Selenium compounds and apoptotic modulation: a new perspective in cancer therapyCarmen Sanmartín, Daniel Plano, Juan Antonio Palop
European Journal of Medicinal Chemistry|October 10, 2022
Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effectsSandra Ramos-Inza, Daniel Plano, Carmen Sanmartín
Molecules (Basel, Switzerland)|February 15, 2022
New Experimental Conditions for Diels-Alder and Friedel-Crafts Alquilation Reactions with Thiophene: A New Selenocyanate with Potent Activity against CancerGorka Calvo-Martín, Daniel Plano, Carmen Sanmartín
Current Cancer Drug Targets|March 15, 2011
Kinase regulation by sulfur and selenium containing compoundsCarmen Sanmartín, Daniel Plano, María Font, et al.
Expert Opinion on Therapeutic Patents|April 4, 2017
Methods of selecting combination therapy for colorectal cancer patients: a patent evaluation of US20160025730A1Daniel Plano, Verónica Alcolea, Carmen Sanmartín, et al.
Antioxidants (Basel, Switzerland)|June 2, 2021
Novel <i>N</i>,<i>N</i>'-Disubstituted Selenoureas as Potential Antioxidant and Cytotoxic AgentsGorka Calvo-Martín, Daniel Plano, Ignacio Encío, et al.
Journal of Molecular Graphics & Modelling|February 26, 2017
Topological and quantum molecular descriptors as effective tools for analyzing cytotoxic activity achieved by a series of (diselanediyldibenzene-4,1-diylnide)biscarbamate derivativesMaría Font, Daniel Plano, Carmen Sanmartín, et al.
Journal of the Science of Food and Agriculture|August 2, 2025
Selenium biofortification: integrating one health and sustainabilitySilvia Estarriaga-Navarro, Nieves Goicoechea, Daniel Plano, et al.
Molecules (Basel, Switzerland)|August 12, 2023
Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania TreatmentAndreina Henriquez-Figuereo, Esther Moreno, Carmen Sanmartin, et al.
Pageof 9